Life Sciences/Biotech

Van Andel Researchers Come Closer To Finding Kindney Cancer Triggers

GRAND RAPIDS - Van Andel Institute researchers have found that when chromosomes stick together during the cell division process, an outcome known as somatic chromosome pairing, the result in two types of kidney cancer is disruption of a gene critical for cellular response to changes in oxygen levels. Somatic chromosome pairing may be present in

By |2008-10-27T00:00:00-04:00October 27th, 2008|Archive, Life Sciences/Biotech|

NanoBio Demonstrates New Topical Approach To Treating Nail Fungus

WASHINGTON, D.C - Ann Arbor-based NanoBio Corp. has demonstrated a new approach to treating nail fungus 50 times stronger than previous treatments. NB-002 has demonstrated a new topical approach to healing nail fungus by penetrating skin pores and diffusing through the skin that surrounds the entire nail plate, according to a study conducted by NanoBio.

By |2008-10-27T00:00:00-04:00October 27th, 2008|Archive, Life Sciences/Biotech|

Oakland University To Host Stem Cell Conference

ROCHESTER - Oakland University will host Stem Cell Research: The Science, the Cures and the Law, an informational conference Oct. 28 at the Oakland Center Banquet Rooms. The forum will be led by Marcia Baum, executive director of Michigan Citizens for Stem Cell Research and Cures, from 6:30-8:30 p.m.. A question and answer session featuring

By |2008-10-21T00:00:00-04:00October 21st, 2008|Archive, Life Sciences/Biotech|

Wayne State University Researches Win Breast Cancer Cure Grants

DETROIT - Susan G. Komen for the Cure has announced the distribution of an unprecedented $100 million in grants to American and international scientists this year to fast track breast cancer research, including three grants worth more than $900,000 given to two Wayne State University researchers. Two researchers from the Barbara Ann Karmanos Cancer Institute

By |2008-10-17T00:00:00-04:00October 17th, 2008|Archive, Life Sciences/Biotech|

Perrigo Acquires Mexican OTC Manufacturer For $25 Million

ALLEGAN - Perrigo Company announced Monday that it has acquired Laboratorios Diba, S.A. for approximately $25 million in cash. Based in Guadalajara, Mexico, privately-held Laboratorios Diba is a store brand manufacturer of over-the-counter and prescription pharmaceuticals, including antibiotics, hormonals and opthalmics. The acquisition is expected to add nearly $15 million of annual sales. "Perrigo has

By |2008-10-06T00:00:00-04:00October 6th, 2008|Archive, Life Sciences/Biotech|

First Anti Stem Cell R&D Ads Hit The Airwaves

LANSING - The first ad on November ballot proposals hit the airwaves Tuesday with opponents of Proposal 2008-2 arguing the plan to allow embryonic stem cell research in the state will mean more costs to taxpayers. If the election were held Tuesday, a majority of voters would support a proposal expanding the use of embryonic

By |2008-09-23T00:00:00-04:00September 23rd, 2008|Archive, Life Sciences/Biotech|

Van Andel Institute Research Find Drug Target For Heart, Blood Diseases

GRAND RAPIDS - Van Andel Institute researchers have determined the molecular structure of a nuclear receptor, which regulates the expression of specific genes within cells, which may serve as a drug target for diseases related to heart and blood vessel development, human embryonic development and female infertility. Researchers also found that the receptor, named COUP-TFII,

By |2008-09-16T00:00:00-04:00September 16th, 2008|Archive, Life Sciences/Biotech|

Wayne State Grad To Receive da Vinci Lifetime Achievement Award

SOUTHFIELD - Jeffery Kocsis has been named to receive the da Vinci Lifetime Achievement Award from the National Multiple Sclerosis Society, Michigan Chapter for his work with new treatment strategies for people with MS. Kocsis received his Ph.D. in 1976 from Wayne State University and has a long history of research and publications on transplantation-based

By |2008-09-03T00:00:00-04:00September 3rd, 2008|Archive, Life Sciences/Biotech|